294 related articles for article (PubMed ID: 21415576)
1. Hemodynamic alterations in cirrhosis and portal hypertension.
Kim MY; Baik SK; Lee SS
Korean J Hepatol; 2010 Dec; 16(4):347-52. PubMed ID: 21415576
[TBL] [Abstract][Full Text] [Related]
2. [Pathophysiology of portal hypertension, what's new?].
Kim MY; Baik SK
Korean J Gastroenterol; 2010 Sep; 56(3):129-34. PubMed ID: 20847603
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of increased intrahepatic resistance in portal hypertension.
Shah V
J Clin Gastroenterol; 2007; 41 Suppl 3():S259-61. PubMed ID: 17975474
[TBL] [Abstract][Full Text] [Related]
5. Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension.
Bosch J; Pizcueta MP; Fernández M; Feu F; Cirera I; Luca A; García-Pagán JC
Baillieres Clin Gastroenterol; 1992 Sep; 6(3):425-36. PubMed ID: 1421593
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of portal hypertension.
Iwakiri Y
Clin Liver Dis; 2014 May; 18(2):281-91. PubMed ID: 24679494
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
Wiest R; Groszmann RJ
Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
[TBL] [Abstract][Full Text] [Related]
8. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.
Bolognesi M; Di Pascoli M; Verardo A; Gatta A
World J Gastroenterol; 2014 Mar; 20(10):2555-63. PubMed ID: 24627591
[TBL] [Abstract][Full Text] [Related]
9. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.
Møller S; Bendtsen F
Liver Int; 2018 Apr; 38(4):570-580. PubMed ID: 28921803
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of portal hypertension.
Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of portal hypertension.
Gupta TK; Chen L; Groszmann RJ
Clin Liver Dis; 1997 May; 1(1):1-12. PubMed ID: 15562664
[TBL] [Abstract][Full Text] [Related]
12. Vascular syndromes in liver cirrhosis.
Shenoda B; Boselli J
Clin J Gastroenterol; 2019 Oct; 12(5):387-397. PubMed ID: 30980261
[TBL] [Abstract][Full Text] [Related]
13. [Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension].
Kim MY; Baik SK
Korean J Gastroenterol; 2009 Sep; 54(3):143-8. PubMed ID: 19844149
[TBL] [Abstract][Full Text] [Related]
14. The beneficial effects of curcumin in cirrhotic rats with portal hypertension.
Hsu SJ; Lee JY; Lin TY; Hsieh YH; Huang HC; Lee FY; Lin HC; Hou MC; Lee SD
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162665
[TBL] [Abstract][Full Text] [Related]
15. Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.
Iwakiri Y; Shah V; Rockey DC
J Hepatol; 2014 Oct; 61(4):912-24. PubMed ID: 24911462
[TBL] [Abstract][Full Text] [Related]
16. [Pathogenesis of portal hypertension].
Montaño-Loza A; Meza-Junco J
Rev Invest Clin; 2005; 57(4):596-607. PubMed ID: 16315644
[TBL] [Abstract][Full Text] [Related]
17. Cediranib ameliorates portal hypertensive syndrome via inhibition of VEGFR-2 signaling in cirrhotic rats.
Fan Q; Wu G; Chen M; Luo G; Wu Z; Huo H; Li H; Zheng L; Luo M
Eur J Pharmacol; 2024 Feb; 964():176278. PubMed ID: 38158116
[TBL] [Abstract][Full Text] [Related]
18. Portal hypertension: from bedside to bench.
Groszmann RJ; Abraldes JG
J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S125-30. PubMed ID: 15758647
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.
Mejias M; Garcia-Pras E; Tiani C; Miquel R; Bosch J; Fernandez M
Hepatology; 2009 Apr; 49(4):1245-56. PubMed ID: 19137587
[TBL] [Abstract][Full Text] [Related]
20. Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats.
Hsu SJ; Lee FY; Wang SS; Hsin IF; Lin TY; Huang HC; Chang CC; Chuang CL; Ho HL; Lin HC; Lee SD
Hepatology; 2015 May; 61(5):1672-84. PubMed ID: 25557829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
